Image1

Clinical Practice Guidelines

SIO is pleased to provide its updated clinical practice guidelines for breast cancer. In June 2018, ASCO announced endorsement of the guidelines. The guidelines were published in 2017. Researchers analyzed which integrative treatments are most effective and safe for patients with breast cancer. The guidelines are a resource for clinicians and patients to inform evidence-based decisions on the use of integrative therapies during breast cancer treatment. Researchers at US and Canadian institutions evaluated the efficacy and safety of more than 80 therapies.

The Journal of the National Cancer Institute Monograph has  published a special issue co-sponsored by SIO, "Advancing the Global Impact of Integrative Oncology"; including a comprehensive definition for integrative oncology. The articles in the special Monograph were all peer-reviewed.


 JACM Announces Call for Submissions (Read more)

                                                                                

nyc 4

SIO 2019 Conference

Standard Registration for the 16th International Conference, October 19-21, 2019 in New York, NY, is open and will remain so until 11:59 pm (ET) October 15, 2019. Don't wait to register! The conference theme is: Advancing the Science and Art of Integrative Oncology. Register here. Hotel Room Blocks are NO LONGER AVAILABLE. However, the hotel may have rooms available at non-conference rates. Please contact them directly: 212-586-7000 or visit their website.


View a list of restaurants near the Hilton Midtown.


As part of the conference, MSKCC will host two tours of its Bendheim Integrative Medicine Center on Saturday morning, October 19, beginning at 10:00 am and 10:30 am. Each tour will be limited to15-20 people per time slot. To ensure your place on a tour, sign up in advance and to get easy directions to the facility using the subway.

SIO 2019 Conference Educational Sponsor

 

MSKlogo 450 h d


May Research Findings

In this interesting vignette based study, 942 physicians and nurses were asked what advice they would give in different patient scenarios where the dynamic variables included patient age and whether the patient finished definitive treatment or not yet. A total of 2303 recommendations were coded and 71.8% regarded an increase in physical activity, 64.3% nutrition, 36.7% psychological support, 29.2% medicine support, 17.2% conscious living, 12.3% naturopathy. Psychological support was increasingly recommended if the patient was still undergoing treatment. Exercise was increasingly recommended if the patient had completed treatment. Considering the growing research evidence that exercise is beneficial even during treatment, this study captures some of the biases and fears clinicians have regarding evidence-informed treatment options. Read the study here.


In an important follow up study, Boyle et al showed that amongst 22 women with breast cancer who completed a 6 week mindfulness meditation intervention, amongst those who had significant increases in eudaimonic well-being (happiness generated by finding a meaning/purpose, as opposed to hedonic well-being which is happiness generated by pursuing objects/activities that produce pleasure, and avoidance of pain) versus those who did not, they had significantly decreased global CTRA (conserved transcriptional response to adversity) scores. But for all 22 women who participated in the study, average global CTRA score did not significantly decrease. Previously the authors and other groups showed that chronic adversity and distress can lead to higher global CTRA scores, i.e. increased expression of pro-inflammatory genes and decreased expression of antiviral and antibody-related genes. This study established that longitudinal changes of eudaimonic well-being within one patient/individual can actually lead to detectable and significant differences in transcriptional response at the cellular level. Of note, the improvements in the global CTRA score amongst patients with improved eudaimonic well-being were primarily driven by an improvement in the antiviral/antibody CTRA component of the score, not the pro-inflammatory CTRA component which had no significant changes. These insights might help scientific investigators better identify the "active ingredients" in an effective mind-body intervention. Read the study here. 

@Integrativeonc

  • Some #SIO2019 Int'l attendees, Patient Advocates, Moderators & Presenters, & New Investigators.…
    https://t.co/g22FN4dxQY

  • @Integrativeonc photos from #SIO2019 Day 1 - early morning pre-conference workshops - stretching and getting ready…
    https://t.co/eJEpF0XvGG

  • Photos from #SIO2019 Day One https://t.co/zYD0JkvHBC